Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS · Delayed Price · Currency is USD
0.49999
+0.00999 (2.04%)
At close: Mar 27, 2026

Pharma-Bio Serv Balance Sheet

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash & Equivalents
5.763.386.7710.4514.4617.47
Short-Term Investments
4.87.485.984.53--
Cash & Short-Term Investments
10.5610.8512.7514.9814.4617.47
Cash Growth
-15.07%-14.84%-14.90%3.56%-17.21%1.93%
Accounts Receivable
2.652.362.513.944.984.61
Receivables
2.652.362.513.944.984.61
Prepaid Expenses
0.110.170.440.480.50.74
Total Current Assets
13.3213.3915.719.419.9422.82
Property, Plant & Equipment
0.10.150.370.390.580.75
Other Long-Term Assets
0.120.120.230.110.130.35
Total Assets
13.5513.6516.2919.920.6523.92
Accounts Payable
0.870.991.131.471.632.09
Current Portion of Leases
-0.030.170.150.140.13
Current Income Taxes Payable
0.720.720.590.530.340.45
Other Current Liabilities
1.72-----
Total Current Liabilities
3.311.741.892.152.112.67
Long-Term Leases
--0.030.190.350.49
Other Long-Term Liabilities
--0.661.431.641.85
Total Liabilities
3.311.742.583.784.095.01
Common Stock
000000
Additional Paid-In Capital
1.691.681.641.61.551.48
Retained Earnings
8.8510.5312.3514.8515.2717.71
Treasury Stock
-0.58-0.58-0.55-0.54-0.5-0.42
Comprehensive Income & Other
0.280.280.260.210.240.14
Shareholders' Equity
10.2411.9113.7216.1316.5618.91
Total Liabilities & Equity
13.5513.6516.2919.920.6523.92
Total Debt
-0.030.190.350.490.62
Net Cash (Debt)
10.5610.8312.5514.6313.9816.85
Net Cash Growth
-14.01%-13.75%-14.21%4.69%-17.07%16.91%
Net Cash Per Share
0.460.470.550.640.610.73
Filing Date Shares Outstanding
22.922.922.9622.9622.9522.97
Total Common Shares Outstanding
22.922.9122.9622.9622.9423
Working Capital
10.0111.6513.8117.2517.8420.15
Book Value Per Share
0.450.520.600.700.720.82
Tangible Book Value
10.2411.9113.7216.1316.5618.91
Tangible Book Value Per Share
0.450.520.600.700.720.82
Machinery
-0.310.680.670.660.64
Updated Jan 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.